DocWire News Editors

DocwireNews

<h2 class="entry-title">Risk Factors for Heart Disease in Young T1D Patients<p>Elevated blood pressure and glucose levels are both significant risk factors for heart disease in young adults with type 1 diabetes (T1D), a new long-term study concluded. The results of the study, &ldquo;Optimal Blood Pressure Goals for Cardiovascular Health in Individuals with Type 1 Diabetes,&rdquo; were presented at the American Diabetes Association&rsquo;s (ADA&rsquo;s) 79th Scientific Sessions at the Moscone Convention Center in San Francisco.</p><p>The study included 605 T1D patients who were diagnosed at age &le; 17 years; patients were followed for 25 years. Patients with elevated blood pressure levels (&ge; 120/80 mm Hg) were twice as likely to develop coronary artery disease (CAD) compared to patients with blood pressure &lt; 120/80 mm Hg.</p><p><a href="https://www.docwirenews.com/conference-coverage/ada-conference/risk-factors-for-heart-disease-in-young-t1d-patients/">Read More</a></p><h2 class="entry-title">Teplizumab Could Delay Diabetes Diagnosis</h2><p>Relatives of type 1 diabetes (T1D) patients are significantly more likely to develop the disease themselves. A recent double-masked, placebo-controlled, randomized trial found that these patients could stave off this diagnosis for as long as two years with immunotherapy. The research was presented at the American Diabetes Association&rsquo;s (ADA&rsquo;s) 79th Scientific Sessions at the Moscone Convention Center in San Francisco.</p><p>Family members of T1D patients and those with multiple antibodies and abnormal glucose tolerance were randomized to receive either teplizumab&mdash;an FcR non-binding humanized monoclonal anti-CD3 antibody&mdash;or placebo. For two weeks, patients received treatment in the form of daily 30-minute intravenous drug infusions.</p><p><a href="https://www.docwirenews.com/conference-coverage/ada-conference/teplizumab-could-delay-diabetes-diagnosis/">Read More</a></p><h2 class="entry-title">Vitamin D Supplements Do Not Prevent Diabetes Onset</h2><p>About 84 million Americans have prediabetes, which puts them at significant risk for progressing to type 2 diabetes. Several lifestyle changes&mdash;such as weight loss and exercise&mdash;could reduce this risk. However, the use of vitamin D supplements may not be a beneficial change, according to research presented at the American Diabetes Association&rsquo;s (ADA) 79th Scientific Sessions at the Moscone Convention Center in San Francisco.</p><p>The study, &ldquo;The Vitamin D and Type 2 Diabetes (D2d) Study &ndash; A Multicenter Randomized Controlled Trial for Diabetes Prevention,&rdquo; included 2,423 adults aged &ge; 30 years with a body mass index between 25 kg/m<sup>2</sup>&nbsp;(23 kg/m<sup>2</sup>&nbsp;for Asian Americans) and 42 kg/m<sup>2</sup>&nbsp;at high risk for diabetes (defined as meeting two of the following prediabetes criteria: fasting glucose 100&ndash; 125 mg/dL [5.6&ndash;6.9 mmol/L], 2-h post load glucose after 75-g glucose load 140&ndash;199 mg/dL [7.8&ndash;11.0 mmol/L], and hemoglobin A1c 5.7&ndash;6.4% [39&ndash;47 mmol/mol]). Patients were randomized to take a daily dose of either 4,000 IU of vitamin D<sub>3</sub>&nbsp;(n = 1,211) or a matching placebo (n = 1,212). During a median 2.5 years of follow-up, patients underwent blood tests every six months to test for diabetes.</p><p><a href="https://www.docwirenews.com/conference-coverage/ada-conference/vitamin-d-supplements-do-not-prevent-diabetes-onset/">Read More</a></p><h3><strong><a href="https://www.docwirenews.com/conference-coverage/ada-2019/">For More Coverage Click Here</a></strong></h3></h2>


Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Breaking News from ADA 2019: June 10, 2019

American Diabetes Association Scientific Sessions 2019

Risk Factors for Heart Disease in Young T1D Patients ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe